These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24159034)

  • 1. Chemistry. Expanding the scope of fluorine tags for PET imaging.
    Zhu L; Ploessl K; Kung HF
    Science; 2013 Oct; 342(6157):429-30. PubMed ID: 24159034
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain amyloid imaging--FDA approval of florbetapir F18 injection.
    Yang L; Rieves D; Ganley C
    N Engl J Med; 2012 Sep; 367(10):885-7. PubMed ID: 22931256
    [No Abstract]   [Full Text] [Related]  

  • 3. Validation of an (18)F-labeled biphenylalkyne as a positron emission tomography imaging agent for beta-amyloid plaques.
    Wey SP; Weng CC; Lin KJ; Yao CH; Yen TC; Kung HF; Skovronsky D; Kung MP
    Nucl Med Biol; 2009 May; 36(4):411-7. PubMed ID: 19423009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amyloid PET imaging with [18F]AV-45].
    Tateno A; Okubo Y
    Nihon Rinsho; 2011 Oct; 69 Suppl 8():561-4. PubMed ID: 22787851
    [No Abstract]   [Full Text] [Related]  

  • 5. Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent.
    Lister-James J; Pontecorvo MJ; Clark C; Joshi AD; Mintun MA; Zhang W; Lim N; Zhuang Z; Golding G; Choi SR; Benedum TE; Kennedy P; Hefti F; Carpenter AP; Kung HF; Skovronsky DM
    Semin Nucl Med; 2011 Jul; 41(4):300-4. PubMed ID: 21624563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid imaging: liberal or conservative? Let the data decide.
    Jagust WJ
    Arch Neurol; 2011 Nov; 68(11):1377-8. PubMed ID: 21747005
    [No Abstract]   [Full Text] [Related]  

  • 7. Florbetapir (18F), a PET imaging agent that binds to amyloid plaques for the potential detection of Alzheimer's disease.
    Okamura N; Yanai K
    IDrugs; 2010 Dec; 13(12):890-9. PubMed ID: 21154149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Florbetapir (18F) for brain amyloid positron emission tomography: highlights on the European marketing approval.
    Cortes-Blanco A; Prieto-Yerro C; Martinez-Lazaro R; Zamora J; Jiménez-Huete A; Haberkamp M; Pohly J; Enzmann H; Zinserling J; Strassmann V; Broich K
    Alzheimers Dement; 2014 Oct; 10(5 Suppl):S395-9. PubMed ID: 24418060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.
    Fleisher AS; Chen K; Liu X; Roontiva A; Thiyyagura P; Ayutyanont N; Joshi AD; Clark CM; Mintun MA; Pontecorvo MJ; Doraiswamy PM; Johnson KA; Skovronsky DM; Reiman EM
    Arch Neurol; 2011 Nov; 68(11):1404-11. PubMed ID: 21747008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent--a pilot study.
    Lin KJ; Hsu WC; Hsiao IT; Wey SP; Jin LW; Skovronsky D; Wai YY; Chang HP; Lo CW; Yao CH; Yen TC; Kung MP
    Nucl Med Biol; 2010 May; 37(4):497-508. PubMed ID: 20447562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A digital revolution in radiosynthesis.
    Reichert DE
    J Nucl Med; 2014 Feb; 55(2):181-2. PubMed ID: 24365652
    [No Abstract]   [Full Text] [Related]  

  • 12. 18F-labeled flavones for in vivo imaging of beta-amyloid plaques in Alzheimer's brains.
    Ono M; Watanabe R; Kawashima H; Kawai T; Watanabe H; Haratake M; Saji H; Nakayama M
    Bioorg Med Chem; 2009 Mar; 17(5):2069-76. PubMed ID: 19201614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of (18) F-Difluoromethylarenes from Aryl (Pseudo) Halides.
    Shi H; Braun A; Wang L; Liang SH; Vasdev N; Ritter T
    Angew Chem Int Ed Engl; 2016 Aug; 55(36):10786-90. PubMed ID: 27491349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET and 18F ligands in the diagnosis of Alzheimer's disease.
    Frisoni GB
    Lancet Neurol; 2011 May; 10(5):397-9. PubMed ID: 21481641
    [No Abstract]   [Full Text] [Related]  

  • 15. From Alois to Amyvid: seeing Alzheimer disease.
    Furst AJ; Kerchner GA
    Neurology; 2012 Oct; 79(16):1628-9. PubMed ID: 22786589
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta amyloid imaging with positron emission tomography (PET) for evaluation of suspected Alzheimer's disease or other causes of cognitive decline.
    Technol Eval Cent Assess Program Exec Summ; 2013 Feb; 27(5):1-4. PubMed ID: 23589929
    [No Abstract]   [Full Text] [Related]  

  • 17. Amyloid-β positron emission tomography in the diagnostic evaluation of alzheimer disease: summary of primary findings and conclusions.
    Pearson SD; Ollendorf DA; Colby JA
    JAMA Intern Med; 2014 Jan; 174(1):133-4. PubMed ID: 24081022
    [No Abstract]   [Full Text] [Related]  

  • 18. Current status of PET-imaging probes of β-amyloid plaques.
    Koo J; Byun Y
    Arch Pharm Res; 2013 Oct; 36(10):1178-84. PubMed ID: 23812777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioactive agent approved as part of Alzheimer disease workup.
    Thompson CA
    Am J Health Syst Pharm; 2012 May; 69(10):818. PubMed ID: 22555074
    [No Abstract]   [Full Text] [Related]  

  • 20. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
    Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.